Resmed Inc
RMD- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000943819
In the last 90 days, Resmed Inc insiders filed 0 open-market purchases and 5 sales; 891 institutions reported holding it in 13F filings for Q2 2026, worth $19.4B in total; Giverny Capital is the only superinvestor holding it.
Other share classesRSMDF
13F holders, Q3 2021
Institutional positions in Resmed Inc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 689
- +35 vs. Q2 2021
- Shares held
- 96.4M
- −346.9K (−0.4%) vs. Q2 2021
- Total value
- $25.4B
- +$1.56B (+6.5%) vs. Q2 2021
- New holders
- 81
- 234 more added
- Sold out
- 46
- 256 more reduced
9 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 891 | $19.4B |
| Q1 2026 | 945 | $21.8B |
| Q4 2025 | 948 | $23.4B |
| Q3 2025 | 949 | $25.1B |
| Q2 2025 | 919 | $23.9B |
| Q1 2025 | 885 | $21.0B |
| Q4 2024 | 872 | $20.7B |
| Q3 2024 | 804 | $21.3B |
| Q2 2024 | 775 | $16.4B |
| Q1 2024 | 719 | $16.5B |
| Q4 2023 | 690 | $14.0B |
| Q3 2023 | 661 | $13.0B |
| Q2 2023 | 733 | $20.8B |
| Q1 2023 | 680 | $20.9B |
| Q4 2022 | 733 | $19.8B |
| Q3 2022 | 668 | $21.0B |
| Q2 2022 | 678 | $20.3B |
| Q1 2022 | 683 | $23.6B |
| Q4 2021 | 724 | $24.6B |
| Q3 2021 | 689 | $25.4B |
| Q2 2021 | 663 | $23.9B |
| Q1 2021 | 664 | $19.2B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Resmed Inc; share changes are against Q2 2021.